Science-based innovation as systematic risk-taking: The case of new drug development

ISSN： 1460-1060

Source： European Journal of Innovation Management, Vol.9, Iss.3, 2006-07, pp. : 300-311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Connectivity and Performance of Science-based Firms

By Rickne Annika

Small Business Economics, Vol. 26, Iss. 4, 2006-05 ,pp. : 393-407

Springer Publishing Company

Access to resources Recommend Favorite

Integrating open innovation to new product development - the case of the Brazilian aerospace industry

By Armellini Fabiano

International Journal of Technological Learning, Innovation and Development, Vol. 5, Iss. 4, 2012-12 ,pp. : 367-384

Inderscience Publishers

Access to resources Recommend Favorite

Innovation and new product development: Sky+, a mini case study

By Philip Cameron

The Marketing Review, Vol. 7, Iss. 4, 2007-12 ,pp. : 313-323

Westburn Publishers Ltd

Access to resources Recommend Favorite

Trust and risk-taking in a pension investment setting

By Hauff Jeanette Carlsson

The International Journal of Bank Marketing, Vol. 32, Iss. 5, 2014-07 ,pp. : 408-428

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Optimal Transparency and Risk-Taking to Avoid Currency Crises

By Bannier Christina E. Heinemann Frank

Journal of Institutional and Theoretical Economics JITE, Vol. 161, Iss. 3, 2005-09 ,pp. : 374-391

Mohr Siebeck

Access to resources Recommend Favorite